Imax (IMAX) looks poised to continue to raise its market share due to its rising global footprint and increasing its partnerships for this year, Wedbush said in a note Wednesday.
"We think Imax can roughly double its screen base and think it should be able to accelerate its annual screen growth as its theater partners return to profitability and have more disposable cash to upgrade theaters," analysts led by Alicia Reese said.
However, Wedbush said it lowered its Q4 estimates on Imax "due to the shortfall on certain titles, including Joker 2 and Kraven the Hunter."
The firm said it now expects Q4 revenue of $103
million on earnings of $0.29 per share, versus its prior estimates of $123 million and $0.44, respectively.
Imax is set to release its Q4 results on Feb. 19.
Wedbush maintained its outperform rating on Imax with a $32 price target.
Price: 25.57, Change: +0.12, Percent Change: +0.45
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.